A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : DM1

Search Conditions:
Search Keyword : DM1
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: DM1
Appearance Frequency: 298 time(s)
Long forms: 90

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
diabetes mellitus type 1
(69 times)
Endocrinology
(11 times)
DM2 (4 times)
STZ (4 times)
ADMA (2 times)
2000 Gliadin antibodies in adult insulin-dependent diabetes--autoimmune and immunogenetic correlates.
disease myotonic dystrophy type 1
(55 times)
Neurology
(21 times)
ALS (2 times)
CTG (2 times)
ICD (2 times)
2002 Increased (CTG/CAG)(n) lengths in myotonic dystrophy type 1 and Machado-Joseph disease genes in idiopathic azoospermia patients.
myotonic dystrophy type 1
(53 times)
Neurology
(24 times)
MBNL1 (5 times)
EDS (3 times)
DM2 (2 times)
2001 Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1.
DM type 1
(14 times)
Neurology
(6 times)
DM (15 times)
DM2 (5 times)
DMPK (2 times)
2005 Hyper-CK-emia as the sole manifestation of myotonic dystrophy type 2.
disease, 16 patients with myotonic dystrophy type 1
(8 times)
Neurology
(3 times)
MRI (2 times)
6MWT (1 time)
APR (1 time)
2007 Eye movement disorders in myotonic dystrophy type 1.
dystrophia myotonica type 1
(5 times)
Genetics, Medical
(3 times)
DMPK (2 times)
ATMs (1 time)
CNS (1 time)
2004 Insulin receptor splicing alteration in myotonic dystrophy type 2.
DMPK, the cause of myotonic dystrophy type 1
(3 times)
Genetic Phenomena
(1 time)
DMR (1 time)
hESC (1 time)
2014 Small molecule kinase inhibitors alleviate different molecular features of myotonic dystrophy type 1.
drug maytansinoid 1
(3 times)
Neoplasms
(2 times)
ADCs (2 times)
CD147 (1 time)
DAR (1 time)
2004 A prostate-specific membrane antigen-targeted monoclonal antibody-chemotherapeutic conjugate designed for the treatment of prostate cancer.
debilitating symptom of myotonic dystrophy type 1
(2 times)
Medicine
(1 time)
AES (1 time)
RNAi (1 time)
2015 Increased autophagy and apoptosis contribute to muscle atrophy in a myotonic dystrophy type 1 Drosophila model.
10  development of type 1 diabetes
(2 times)
Endocrinology
(1 time)
--- 2008 [Oxidative stress: a review on metabolic signaling in type 1 diabetes].
11  diabetes mellitus of type 1
(2 times)
Physiology
(1 time)
ACSS (1 time)
2001 [Role of dysbacteriosis in the formation of chronic noninfectious pathology in children].
12  differences to that of myotonic dystrophy type 1
(2 times)
Neurology
(2 times)
DOSS (1 time)
FEES (1 time)
2008 Gastrointestinal involvement is frequent in Myotonic Dystrophy type 2.
13  dystrophy: (i) myotonic dystrophy type 1
(2 times)
Molecular Biology
(1 time)
DM2 (1 time)
2010 The myotonic dystrophies: diagnosis and management.
14  N(2')-deacetyl-N(2')-(3-mercapto-1-oxopropyl)-maytansine
(2 times)
Neoplasms
(1 time)
AMCs (1 time)
DDI (1 time)
DM4 (1 time)
2004 In vitro and in vivo activity of the maytansinoid immunoconjugate huN901-N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine against CD56+ multiple myeloma cells.
15  4-(5-(4-hydroxy-3-methoxyphenyl)-3-oxo-penta-1,4-dienyl)-2-methoxy-phenolate
(1 time)
Biochemistry
(1 time)
--- 2016 Evaluation of the anti-inflammatory action of curcumin analog (DM1): Effect on iNOS and COX-2 gene expression and autophagy pathways.
16  daily living, in adults with myotonic dystrophy type 1
(1 time)
Rehabilitation
(1 time)
AMPS (1 time)
COPM (1 time)
2013 Effects of hand-training in persons with myotonic dystrophy type 1--a randomised controlled cross-over pilot study.
17  Data concerning ADMA level in type 1 diabetes
(1 time)
Endocrine System Diseases
(1 time)
ADMA (1 time)
2010 [Asymmetric dimethylarginine (ADMA) in children with diabetes type 1].
18  data of muscles in myotonic dystrophy type 1
(1 time)
Neurology
(1 time)
MRI (1 time)
2018 Lower limb muscle magnetic resonance imaging in myotonic dystrophy type 1 correlates with the six-minute walk test and CTG repeats.
19  date, two types of myotonic dystrophy, type 1
(1 time)
Neurology
(1 time)
MBNL (1 time)
2011 Myotonic dystrophy types 1 and 2.
20  daytime sleepiness are frequent complaints in myotonic dystrophy type 1
(1 time)
Neurology
(1 time)
--- 2013 Fatigue and daytime sleepiness scale in myotonic dystrophy type 1.
21  debilitating symptom experienced by individuals with myotonic dystrophy type 1
(1 time)
Science
(1 time)
MBNL1 (1 time)
2008 Expanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy.
22  defects, is common in myotonic dystrophy type 1
(1 time)
Neurology
(1 time)
CHF (1 time)
2011 Congestive heart failure after physical exercise in a young patient with myotonic dystrophy type 1.
23  deltamethrin were very stereospecific, detecting the alphaS, 1R cis
(1 time)
Chemistry
(1 time)
--- 1998 Development of Immunoassays for Type II Synthetic Pyrethroids. 1. Hapten Design and Application to Heterologous and Homologous Assays.
24  dementia component of myotonic dystrophy type 1
(1 time)
Molecular Biology
(1 time)
AD (1 time)
DS (1 time)
NFTs (1 time)
2011 An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.
25  dental care in children with myotonic dystrophy type 1
(1 time)
Dentistry
(1 time)
DMFT (1 time)
TMD (1 time)
2009 Oral health status in a group of children and adolescents with myotonic dystrophy type 1 over a 4-year period.
26  depression and anxiety symptoms in myotonic dystrophy type 1
(1 time)
Psychiatry
(1 time)
--- 2019 Affective symptoms and apathy in myotonic dystrophy type 1 a systematic review and meta-analysis.
27  derivative of maytansine 1
(1 time)
Nucleic Acids
(1 time)
5-FU (1 time)
ApDCs (1 time)
MMAE (1 time)
2017 Aptamer-Drug Conjugates of Active Metabolites of Nucleoside Analogs and Cytotoxic Agents Inhibit Pancreatic Tumor Cell Growth.
28  dermal blood vessels in adults with type 1 diabetes
(1 time)
Vascular Diseases
(1 time)
AGEs (1 time)
AUC (1 time)
IHC (1 time)
2019 Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetes.
29  describe the first case of myotonic dystrophy type 1
(1 time)
Neurology
(1 time)
FSHD (1 time)
2013 Myotonic dystrophy type 1 and de novo FSHD mutation double trouble: a clinical and muscle MRI study.
30  described as a frequent feature in myotonic dystrophy type 1
(1 time)
Neurology
(1 time)
--- 2008 Familial aggregation of white matter lesions in myotonic dystrophy type 1.
31  described the involvement pattern of myotonic dystrophy type 1
(1 time)
Medicine
(1 time)
--- 2018 Five-year serial follow-up of muscle MRI in adult onset myotonic dystrophy type 1: A case report.
32  designed, multi-target agents for myotonic dystrophy type 1
(1 time)
Chemistry
(1 time)
MBNL (1 time)
RAN (1 time)
2015 Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1.
33  destruction of pancreatic islets protecting from type 1 diabetes
(1 time)
Allergy and Immunology
(1 time)
--- 2014 Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up.
34  detecting CTG trinucleotide repeats in myotonic dystrophy type 1
(1 time)
Genetics, Medical
(1 time)
TP-PCR (1 time)
2012 [Detection for trinucleotide repeats in myotonic dystrophy type 1].
35  developed for myotonic dystrophy type 1
(1 time)
Neurology
(1 time)
HRs (1 time)
NIV (1 time)
2018 Genotype and other determinants of respiratory function in myotonic dystrophy type 1.
36  development of microvascular complications in patients with type 1 diabetes
(1 time)
Allergy and Immunology
(1 time)
BMI (1 time)
FPG (1 time)
IL-6 (1 time)
2013 Association between IL-6 concentration and diabetes-related variables in DM1 patients with and without microvascular complications.
37  diabetic for 1 month
(1 time)
Reproductive Medicine
(1 time)
DM3 (1 time)
2015 Diabetes-induced oxidative DNA damage alters p53-p21CIP1/Waf1 signaling in the rat testis.
38  diagnostic potential of FMSF for type 1 diabetes
(1 time)
Vascular Diseases
(1 time)
FMSF (1 time)
2019 Flow Mediated Skin Fluorescence technique reveals remarkable effect of age on microcirculation and metabolic regulation in type 1 diabetes.
39  DIF metabolite 1
(1 time)
Biochemistry
(1 time)
DIF-1 (1 time)
1995 The proximal pathway of metabolism of the chlorinated signal molecule differentiation-inducing factor-1 (DIF-1) in the cellular slime mould Dictyostelium.
40  different characteristics of patients with myotonic dystrophy type 1
(1 time)
Cardiology
(1 time)
BPI (1 time)
INQoL (1 time)
2015 Multidimensional aspects of pain in myotonic dystrophies.
41  different genes have been identified: myotonic dystrophy type 1
(1 time)
Neurology
(1 time)
DM (1 time)
2017 Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects.
42  different mechanisms underlying the etiopathogenesis of myotonic dystrophy type 1
(1 time)
Biochemistry
(1 time)
--- 2009 Altered splicing of Tau in DM1 is different from the foetal splicing process.
43  differentiating myoblasts isolated from healthy and myotonic dystrophy type 1
(1 time)
Biophysics
(1 time)
--- 2009 Potassium currents in human myogenic cells from healthy and congenital myotonic dystrophy foetuses.
44  disabling features in adult-onset myotonic dystrophy type 1
(1 time)
Neurology
(1 time)
--- 2011 Sleep disorders in adult-onset myotonic dystrophy type 1: a controlled polysomnographic study.
45  disease burden and 17 areas of Myotonic Dystrophy type 1
(1 time)
Neurology
(1 time)
MDHI (1 time)
2017 The Myotonic Dystrophy Health Index: Italian validation of a disease-specific outcome measure.
46  disease components in a unique myotonic dystrophy type 1
(1 time)
Neurology
(1 time)
CMT (1 time)
2009 Encephalopathic attacks in a family co-segregating myotonic dystrophy type 1, an intermediate Charcot-Marie-Tooth neuropathy and early hearing loss.
47  disease for RNAi therapy application is myotonic dystrophy type 1
(1 time)
Genetics, Medical
(1 time)
rAAV (1 time)
RNAi (1 time)
2015 Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy.
48  disease mechanism underlying myotonic dystrophy type 1
(1 time)
Cardiology
(1 time)
--- 2005 Nuclear RNA foci in the heart in myotonic dystrophy.
49  disease much more common in type 1 diabetic patients
(1 time)
Endocrinology
(1 time)
EGD (1 time)
PA (1 time)
2005 Serum pepsinogen I: an early marker of pernicious anemia in patients with type 1 diabetes.
50  disease progression in adults with myotonic dystrophy type 1
(1 time)
Rehabilitation
(1 time)
ADL (1 time)
2011 Functioning and disability in adults with myotonic dystrophy type 1.
51  disease severity and therapeutic response in myotonic dystrophy type 1
(1 time)
Neurology
(1 time)
ADF (1 time)
TA (1 time)
2013 Splicing biomarkers of disease severity in myotonic dystrophy.
52  diseases are currently known: the myotonic dystrophy type 1
(1 time)
Neurology
(1 time)
--- 2018 [Dystrophic and non-dystrophic myotonias].
53  diseases caused by microsatellite expansions, particularly myotonic dystrophy type 1
(1 time)
Biology
(1 time)
Mbl (1 time)
MBNL1 (1 time)
2011 Alternative splicing regulation by Muscleblind proteins: from development to disease.
54  diseases include, among others, myotonic dystrophy type 1
(1 time)
Biochemistry
(1 time)
ALS/FTD (1 time)
FISH (1 time)
FXTAS (1 time)
2016 RNA FISH for detecting expanded repeats in human diseases.
55  disorder clinically similar to myotonic dystrophy type 1
(1 time)
Biotechnology
(1 time)
DMPK (1 time)
ZNF9 (1 time)
2005 Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population.
56  distinct from myotonic dystrophy type 1
(1 time)
Neurology
(1 time)
--- 2002 Myotonic dystrophy type 2.
57  disturbances are common in myotonic dystrophy type 1
(1 time)
Neurology
(1 time)
DM2 (1 time)
EDS (1 time)
OSA (1 time)
2013 Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2.
58  DM are identified - type 1
(1 time)
Neurology
(1 time)
DM (1 time)
2010 [Myotonic dystrophy - a new insight into a well-known disease].
59  DM for 1 month
(1 time)
Pathology
(1 time)
DM (1 time)
DR (1 time)
HIF-1alpha (1 time)
2015 Survivin contributes to the progression of diabetic retinopathy through HIF-1alpha pathway.
60  DM have been identified: type 1
(1 time)
Cardiology
(1 time)
CTG (1 time)
DM (1 time)
2011 Progressive conduction disturbance in myotonic dystrophy.
61  DM is nucleotide repeat expansion disorder in which type 1
(1 time)
Biomedical Research
(1 time)
DM (1 time)
iPSC (1 time)
MBNL1 (1 time)
2019 Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes.
62  DM of both type 1
(1 time)
Geriatrics
(1 time)
AGEs (1 time)
BMD (1 time)
DM (1 time)
2011 Osteoporosis and risk of fracture in patients with diabetes: an update.
63  DM of type 1
(1 time)
Medicine
(1 time)
DM (1 time)
DM2 (1 time)
2008 Repeat length and RNA expression level are not primary determinants in CUG expansion toxicity in Drosophila models.
64  DM1 patients without associated autoantibodies
(1 time)
Endocrinology
(1 time)
CAG (1 time)
2009 Regulatory T cells in type 1 diabetic patients with autoimmune chronic atrophic gastritis.
65  DMPK CTG repeat cause myotonic dystrophy type 1
(1 time)
Molecular Biology
(1 time)
--- 2015 Efficient and highly sensitive screen for myotonic dystrophy type 1 using a one-step triplet-primed PCR and melting curve assay.
66  DMPK CTG-repeat expansions that cause myotonic dystrophy type 1
(1 time)
Molecular Biology
(1 time)
MCA (1 time)
TP-PCR (1 time)
2016 Defining the performance parameters of a rapid screening tool for myotonic dystrophy type 1 based on triplet-primed PCR and melt curve analysis.
67  DMPK gene in healthy and myotonic dystrophy type 1
(1 time)
Neurology
(1 time)
--- 2005 Haplotype analysis of the DM1 locus in the Serbian population.
68  DMPK gene on chromosome 19q13
(1 time)
Cardiology
(1 time)
CTG (1 time)
2006 Italian guidelines for molecular analysis in myotonic dystrophies.
69  DMPK gene, indicative of Myotonic Dystrophy Type 1
(1 time)
Cell Biology
(1 time)
--- 2016 Derivation of DM1 affected human embryonic stem cell line Genea067.
70  DMPK, the gene mutated in myotonic dystrophy type 1
(1 time)
Biochemistry
(1 time)
miRNAs (1 time)
2015 Cooperation meets competition in microRNA-mediated DMPK transcript regulation.
71  DNA and RNA in myotonic dystrophy type 1
(1 time)
Science
(1 time)
--- 2019 Intrinsically cell-penetrating multivalent and multitargeting ligands for myotonic dystrophy type 1.
72  DNA reference material panel for myotonic dystrophy type 1
(1 time)
Molecular Biology
(1 time)
--- 2013 Development of a genomic DNA reference material panel for myotonic dystrophy type 1 (DM1) genetic testing.
73  DNA testing guidelines for myotonic dystrophy type 1
(1 time)
Neurology
(1 time)
IDMC (1 time)
2000 New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). The International Myotonic Dystrophy Consortium (IDMC).
74  DNA which causes myotonic dystrophy type 1
(1 time)
Biochemistry
(1 time)
VDAT (1 time)
2018 Selective alkylation of T-T mismatched DNA using vinyldiaminotriazine-acridine conjugate.
75  DNA-testing program for myotonic dystrophy type 1
(1 time)
Genetics, Medical
(1 time)
--- 2004 Psychosocial impact of predictive testing for myotonic dystrophy type 1.
76  domains in people with myotonic dystrophy type 1
(1 time)
Physical Medicine
(1 time)
OR (1 time)
2008 Predictors of disrupted social participation in myotonic dystrophy type 1.
77  donors (n=3) and myotonic dystrophy type 1
(1 time)
Cell Biology
(1 time)
ASO (1 time)
CAG (1 time)
CCND1 (1 time)
2016 Reliable and versatile immortal muscle cell models from healthy and myotonic dystrophy type 1 primary human myoblasts.
78  drive of expanded CTG repeats in myotonic dystrophy type 1
(1 time)
Genetics, Medical
(1 time)
LBCLs (1 time)
2001 "Mitotic drive" of expanded CTG repeats in myotonic dystrophy type 1 (DM1).
79  duration of AF episodes in myotonic dystrophy type 1
(1 time)
Cardiology
(1 time)
APP (1 time)
PM (1 time)
2012 Right atrial preference pacing algorithm in the prevention of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: a long term follow-up study.
80  during recovery in patients with myotonic dystrophy type 1
(1 time)
Physiology
(1 time)
DelayTOT (1 time)
EMG (1 time)
HC (1 time)
2017 Electromechanical delays during a fatiguing exercise and recovery in patients with myotonic dystrophy type 1.
81  dysfunction as a contributor to myotonic dystrophy type 1
(1 time)
Biology
(1 time)
--- 2001 Drosophila homolog of the myotonic dystrophy-associated gene, SIX5, is required for muscle and gonad development.
82  dysfunction in adult onset myotonic dystrophy type 1
(1 time)
Neurology
(1 time)
--- 2006 Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and type 2 (DM2).
83  dysfunction in the childhood form of myotonic dystrophy type 1
(1 time)
Neurology
(1 time)
--- 2011 A new window on neurocognitive dysfunction in the childhood form of myotonic dystrophy type 1 (DM1).
84  dysfunction in the progeny of women with diabetes type 1
(1 time)
Gynecology
(1 time)
--- 1999 [Prospective neurological analysis of development of children of mothers with IDDM].
85  dystrophia myotonica 1
(1 time)
Genetics, Medical
(1 time)
DMPK (1 time)
TRD (1 time)
2006 Transmission ratio distortion in the myotonic dystrophy locus in human preimplantation embryos.
86  dystrophy has two forms, myotonic dystrophy type 1
(1 time)
Neurology
(1 time)
CDM1 (1 time)
2017 Cardiac Abnormalities in Congenital and Childhood Myotonic Muscular Dystrophy Type 1.
87  muscular dystrophy type 1
(1 time)
Biochemistry
(1 time)
--- 2018 Small molecule alteration of RNA sequence in cells and animals.
88  non-demented myotonic dystrophy type 1
(1 time)
Neurology
(1 time)
ERPs (1 time)
LORETA (1 time)
2012 Cognition and event-related potentials in adult-onset non-demented myotonic dystrophy type 1.
89  S2-DM1 cells expressing a Drosophila muscarinic acetylcholine receptor
(1 time)
Cell Biology
(1 time)
--- 1999 Functional characterization of thapsigargin and agonist-insensitive acidic Ca2+ stores in Drosophila melanogaster S2 cell lines.
90  T-DM1 to CKAP5 is mediated by payload
(1 time)
Neoplasms
(1 time)
ADCs (1 time)
CKAP5 (1 time)
2018 Payload of T-DM1 binds to cell surface cytoskeleton-associated protein 5 to mediate cytotoxicity of hepatocytes.